Encysive Dispute Resolution Request For Thelin Negged By FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Securing approval by conducting an additional Phase III study as requested by FDA would take years, CEO Cole tells “The Pink Sheet” DAILY.